2024•International Forum of Allergy & RhinologyOpen access

Impact of dupilumab prescribing on utilization of medical and surgical therapies for chronic rhinosinusitis with nasal polyps

Christopher M. Low, Allan Wang, Michael Yong, Jayakar V. Nayak, Zara M. Patel, Peter H. Hwang

Abstract

KEY POINTS: Increased dupilumab utilization coincided with decreased ESS in patients with CRSwNP between 2019 and 2021. One potential confounder was the concurrent COVID-19 pandemic, which may have negatively impacted surgery utilization rates.

Open-access reader

About this research paper

What this paper is about

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Dupilumab, Nasal polyps, Chronic rhinosinusitis, Medicine, Coronavirus disease 2019 (COVID-19), Sinusitis, Dermatology, Internal medicine